ClinVar Miner

Submissions for variant NM_000256.3(MYBPC3):c.2738-2A>T

dbSNP: rs1595842632
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Agnes Ginges Centre for Molecular Cardiology, Centenary Institute RCV000999579 SCV001156280 likely pathogenic Hypertrophic cardiomyopathy 2018-10-16 criteria provided, single submitter research The MYBPC c.2738-2A>T variant is not observed in large population databases such as the Genome Aggregation Database (http://gnomad.broadinstitute.org/). We have identified this variant in one proband with HCM (Ingles J, et al., 2017). This variant affects the canonical splice acceptor site of intron 26, and is therefore predicted to cause abnormal splicing. Interestingly, other rare variants at this position (c.2738-2A>C; c.2738-2A>G) have been reported in HCM patients (Zou Y, et al., 2013; Walsh R, et al., 2017), suggesting that single nucleotide changes at this position may not be tolerated. Loss of function variants in MYBPC3 are a known mechanism of disease in HCM and splice variants in MYBPC3 have been shown to be disease-causing. Hence, we classify MYBPC3 c.2738-2A>T as "likely pathogenic".

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.